|  | 
| MechanismNF-κB inhibitors | 
| Active Org.- | 
|  | 
| Active Indication- | 
|  | 
| Drug Highest PhasePending | 
| First Approval Ctry. / Loc.- | 
| First Approval Date- | 
100 Clinical Results associated with Ashbury Biologicals, Inc.
0  Patents (Medical) associated with Ashbury Biologicals, Inc.
100 Deals associated with Ashbury Biologicals, Inc.
100 Translational Medicine associated with Ashbury Biologicals, Inc.